(Q45283754)

11 December 2017

title

Eosinophil activation in systemic sclerosis (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

9 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

9 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

9 December 2022

author name string

R. Gustafsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849409

9 December 2022

K. Fredens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849409

9 December 2022

O. Nettelbladt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849409

9 December 2022

R. Hällgren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849409

9 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1849409

9 December 2022

publication date

1 April 1991

1 reference

full work available at URL

11 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780340406

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780340406

9 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

9 December 2022

published in

Arthritis & Rheumatology

1 reference

11 December 2017

Arthritis and Rheumatism

34

4

414–22

April 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1849409

9 December 2022

volume

34

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

414-422

1 reference

Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FART.1780340406

Toxic effects of human eosinophil products on isolated rat heart cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780340406

The immunopathology of progressive systemic sclerosis (PSS).

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Systemic scleroderma. Clinical and pathophysiologic aspects

9 December 2022

2

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

The cardiovascular manifestations of systemic sclerosis (scleroderma)

9 December 2022

3

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Skin capillary blood flow in scleroderma

9 December 2022

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Cold-induced reversible myocardial ischaemia in systemic sclerosis

9 December 2022

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Cellular infiltrates in scleroderma skin

9 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

9 December 2022

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

9 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis

9 December 2022

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast

9 December 2022

10

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Fibroblast selection in scleroderma. An alternative model of fibrosis

9 December 2022

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Increased expression of platelet-derived growth factor type b receptors in the skin of patients with systemic sclerosis

9 December 2022

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis

9 December 2022

14

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

The eosinophilic leukocyte: structure and function

9 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement

9 December 2022

17

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Eosinophil cationic protein (ECP) in the cerebrospinal fluid

9 December 2022

18

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

The American Review of Respiratory Disease

9 December 2022

19

135

639

Hällgren

1987

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function

9 December 2022

20

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents

9 December 2022

21

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease

9 December 2022

23

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein

9 December 2022

25

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

9 December 2022

26

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein

9 December 2022

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage.

9 December 2022

33

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Radioimmunoassay of Human Eosinophil Cationic Protein

9 December 2022

34

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells?

9 December 2022

36

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Eosinophils and resistance to Trichinella spiralis

9 December 2022

39

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Recombinant human interleukin 5 is a selective activator of human eosinophil function

9 December 2022

41

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

9 December 2022

42

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

9 December 2022

43

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis

9 December 2022

46

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Dermatologische Monatschrift

9 December 2022

47

172

86

Ziegler

1986

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

9 December 2022

48

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan

9 December 2022

49

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

On scleroderma. Mast cells, endothelial cells, and fibroblasts

9 December 2022

52

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

The Role of the Eosinophil Granulocyte in the Inflammatory Reaction

9 December 2022

53

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro

9 December 2022

56

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Mechanism of membrane damage mediated by human eosinophil cationic protein

9 December 2022

60

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Prognostic role of eosinophils in pulmonary fibrosis

9 December 2022

62

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease.

9 December 2022

63

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis

9 December 2022

64

1 reference

https://api.crossref.org/works/10.1002/ART.1780340406

9 December 2022

Identifiers

1 reference

11 December 2017

1 reference